D.A. Davidson & CO. lessened its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 249,733 shares of the company’s stock after selling 4,332 shares during the period. D.A. Davidson & […]